Although deletion of certain autophagy-related genes has been associated with defects in hematopoiesis, it remains unclear whether hyperactivated mitophagy affects the maintenance and differentiation of hematopoietic stem cells (HSCs) and committed progenitor cells. Here we report that targeted deletion of the gene encoding the AAA+ -ATPase Atad3a hyperactivated mitophagy in mouse hematopoietic cells. Affected mice showed reduced survival, severely decreased bone-marrow cellularity, erythroid anemia and B cell lymphopenia. Those phenotypes were associated with skewed differentiation of stem and progenitor cells and an enlarged HSC pool. Mechanistically, Atad3a interacted with the mitochondrial channel components Tom40 and Tim23 and served as a bridging factor to facilitate appropriate transportation and processing of the mitophagy protein Pink1. Loss of Atad3a caused accumulation of Pink1 and activated mitophagy. Notably, deletion of Pink1 in Atad3a-deficient mice significantly 'rescued' the mitophagy defect, which resulted in restoration of the progenitor and HSC pools. Our data indicate that Atad3a suppresses Pink1-dependent mitophagy and thereby serves a key role in hematopoietic homeostasis.
M itochondria are multifunctional cellular organelles involved in energy metabolism, the production of reactive oxygen species (ROS), apoptosis, signal transduction and nuclear genome transcription [1] [2] [3] . Mitochondrial aberrations have been reported in various hematopoietic disorders [4] [5] [6] . The role of mitochondria in hematopoiesis is complicated. Mitochondrial contents and activity are maintained at low levels in HSCs to avoid ROS damage [7] [8] [9] . However, defective mitochondrial energy metabolism can cause depletion of HSCs, which indicates that mitochondria might be also required for HSCs [10] [11] [12] . Notably, mitochondrial contents and activity increase during differentiation and progenitor expansion [7] [8] [9] . Thus, the mitochondrial contents might be necessarily maintained at a steady state.
Mitochondrial homeostasis is maintained by both biogenesis and mitophagy. The deletion of genes encoding autophagy-promoting molecules is associated with the accumulation of mitochondria and defective hematopoiesis [13] [14] [15] , which suggests that mitophagy might be required for hematopoiesis. A specific study of mitophagy has demonstrated that the inhibition of mitophagy by knockdown of the ubiquitin ligase Parkin or Pink1 impairs the self-renewal ability of HSCs 16 . However, since those findings were all derived from autophagy-mitophagy-inhibition models, there is a lack of evidence and mechanistic understanding of the effect of hyperactivated mitophagy on the maintenance of HSCs and the differentiation of those stem cells and committed hematopoietic progenitor cells.
The mitochondrial surface receptors for the ubiquitin-like protein LC3, including Nix, Bnip3 and Func1, can recruit LC3 and trigger mitophagy [17] [18] [19] . On the other hand, the Pink1-Parkin pathway activates mitophagy in an ubiquitination-dependent manner. Mitochondrial damage causes Pink1 to accumulate on the mitochondrial surface and recruits Parkin to ubiquitinate multiple mitochondrial proteins. Ubiquitinated proteins recruit LC3 through ubiquitin-binding adaptors to activate mitophagy 20, 21 . In contrast, healthy mitochondria escape from mitophagy by importing Pink1 for processing and degradation and thus restrict the abundance of Pink1 (ref. 22 ). Two complexes in the outer membrane and inner membrane, the TOM and TIM complexes, respectively, are required for the import of Pink1 through the membranes 23 . However, the molecular mechanism by which Pink1 is transported from the TOM complex to the TIM complex remains poorly understood.
The AAA+-ATPase (' ATPase associated with diverse cellular activities') Atad3a was identified as a mitochondrial protein that spans the inner membrane with its two terminal domains located in the outer membrane and the matrix 24 . Deletion of Atad3a in mice causes embryonic death at the early post-implantation stage, during which increased mitochondrial activity is required 25 . However, the underlying mechanism by which Atad3a regulates mitochondrial homeostasis and activity remains unclear. Interestingly, a published study has shown that Atad3a variant Atad3a
Arg528Trp in the fibroblasts of a single patient was associated with activation of mitophagy 26 , indicative of a potential role for Atad3a in the regulation of mitophagy.
Here we report the generation of mice with conditional knockout of Atad3a in the hematopoietic system. We found that Atad3a bridged between the TOM complex and TIM complex to facilitate the import of Pink1 into mitochondria for processing. Atad3a prevented aberrant accumulation of Pink1 and the consequent recruitment of Parkin to the mitochondria. Atad3 thus functions as a suppressor of mitophagy and has a key role in maintaining mitochondrial homeostasis.
Results
Atad3a deletion skews hematopoietic differentiation. We found that HSCs and committed progenitor cells had higher expression of Atad3a than that of mature hematopoietic cells (Fig. 1a) . Thus, we concluded that Atad3a might be specifically required in HSCs and progenitor cells. We therefore generated Atad3a fl/fl Mx1Cre mice, in which Cre recombinase activity is induced by the synthetic analog of double-stranded RNA poly(I:C) to effect deletion of Atad3a specifically in adult hematopoietic cells 11, 27 ( Supplementary Fig. 1a ,b). Treatment with poly(I:C) did not affect lineage-marker-positive (Lin + ) cell populations in Mx1Cre mice ( Supplementary Fig. 1c ) but caused impaired survival of Atad3a fl/fl Mx1Cre mice (Fig. 1b) , with a significant reduction in total cells in the bone marrow, spleen and thymus (Fig. 1c-e) , as well as a progressive decrease in white blood cells, lymphocytes, red blood cells, platelets and hemoglobin in the peripheral blood (Fig. 1f) . Consistent with that, deletion of Atad3a led to severe anemia and B cell lymphopenia in bone marrow, as indicated by a reduction of Ter119 + erythroid cells and B220 + lymphocytes ( Fig. 1g and Supplementary Fig. 1d) ; however, the proportion of Gr1
+

Mac1
+ myeloid cells was increased ( Fig. 1g and Supplementary Fig. 1d ). Collectively, these results showed that Atad3a was crucial for normal hematopoiesis.
Atad3a is an intrinsic regulator of hematopoiesis. To determine whether Atad3a is an intrinsic regulator of hematopoiesis, we isolated CD45.2 + Atad3a fl/fl or Atad3a fl/fl Mx1Cre bone marrow cells 1 d after treatment of the mice with poly(I:C), then transplanted the cells into lethally irradiated CD45.1 + wild-type recipient mice. Mice that received Atad3a-deficient (Atad3a fl/fl Mx1Cre) bone marrow died rapidly, whereas recipients given transplantation of Atad3a fl/fl donor cells all survived (Fig. 2a) . Thus, the Atad3a-deficient hematopoietic cells had cell-autonomous defects.
We then reconstituted the bone marrow of lethally irradiated CD45. Mx1Cre mice (key). *P < 0.05, **P < 0.01 and ***P < 0.001, LT-HSC versus Lin + in a (one-way analysis of variance (ANOVA) followed by Bonferroni post-hoc test (a), log-rank (Mantel Cox) test (b) or Student's t-test (c-g)). Data are representative of two independent experiments (a; mean + s.d. of n = 3 biological replicates) or three independent experiments with n = 10 mice per group (b) or are from two independent experiments (c-e,g (average); mean ± s.d. of n = 8 mice per genotype (c-e), or n = 6 mice per genotype (g) or n ≥ 3 mice per genotype (f)). Supplementary Fig. 2a,b) ), into lethally irradiated wild-type recipient mice. The resulting chimeric mice were successfully reconstituted, as shown by a similar frequency of CD45.2 + donor-derived peripheral blood cells at week 5 ( Fig. 2c) . At 6 weeks after transplantation, the chimeric mice received poly(I:C) to induce Cre activity. The mice reconstituted with Atad3a fl/fl Mx1Cre bone marrow showed a modest but significant progressive reduction of donor derived CD45. 
+ myeloid cells in bone marrow of the chimeric recipient mice 12 weeks after treatment with poly(I:C) ( Fig. 2f and Supplementary Fig. 2c ). Since Ter119 + cells were negative for both CD45.2 and CD45.1, the effect of Atad3a deletion on erythropoiesis could not be determined in this competitive bone-marrow-transplantation assay ( Supplementary Fig. 2d) Fig. 2e,g ). In contrast, the frequency of CD45.2 + cells in Mac1 + population remained constant ( Supplementary Fig. 2f,g ). The enhanced frequency of donorderived Atad3a-deficient CD45.2 + Mac1 + cells might have been due to compensation for the reduction in the CD45.2 + B220 + population. We concluded that Atad3a was required in a cell-intrinsic manner for appropriate hematopoiesis.
Atad3a regulates stem and progenitor cells. To investigate how Atad3a regulates hematopoiesis, we assessed HSCs and progenitor cells in Atad3a-deficient bone marrow. We used a gating strategy with the signaling-lymphocytic-activation-molecule receptors CD150 and CD48 to identify HSC populations [28] [29] [30] ( Supplementary  Fig. 3a ). Subsequent to Cre-mediated deletion of Atad3a, the frequency and number of cells in 'early' HSC compartments and progenitor populations consistently increased. These included the following: Lin 
CD48
+ multipotent progenitors (MPPs) (Fig. 3a-c) . The frequency of MPPs, but not that of HSCs, in the LSK compartment was also increased (Supplementary Fig. 3b ).
The enlarged populations of LSK cells, HSCs and MPPs might have resulted from increased proliferation, increased cell survival and/or decreased differentiation. Incorporation of the thymidine analog BrdU into Atad3a-deficient cells was less than that in Atad3a fl/fl cells ( Supplementary Fig. 3c ), which suggested impaired proliferation of the former cells. Atad3a deficiency also increased cellular apoptosis (Supplementary Fig. 3d ). These results indicated that the accumulation of HSCs, MPPs and LSK cells in Atad3a-deficient bone marrow might have been caused by blocked commitment to or differentiation into the hematopoietic lineage.
HSCs and LSK cells differentiate into common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs). CMPs further differentiate into megakaryocyte erythroid progenitors (MEPs) and granulocyte macrophage progenitors (GMPs) 31 . Deletion of Atad3a caused a decrease in the absolute number of CMPs, although the frequency of CMPs was not significantly reduced ( Fig. 3d-f) . The frequency of CMPs in the Atad3a-deficient Lin Fig. 3e ). To our surprise, Atad3a deficiency increased the CLP population (Fig. 3d,e and Supplementary Fig. 3f ). We inferred that Atad3a not only was required for the differentiation but was also critical for the fate 'decision' from LSK cell to CMP but not from LSK cell to CLPs.
Furthermore, Atad3a appeared to be necessary for the differentiation and fate 'decision' from CMP to MEP but not that from CMP to GMP. Deletion of Atad3a severely reduced the MEP population but increased the GMP population (Fig. 3d-f) . The result of this disparate effect on the distinct progenitors was manifested by changes in more-mature cells expressing lineage-specific surface markers. We observed an increase in Gr1
+
Mac1
+ myeloid cells but a decrease in all stages of Ter119 + erythroid cells ( Fig. 3g and Supplementary Fig. 3g ). Consistent with the reduction in erythroid-progenitor and erythroidlineage cells, the colony-forming ability of CMPs and MEPs was impaired after deletion of Atad3a ( Supplementary Fig. 3h ).
Despite an increase in CLPs, cells of the B220
+ lineage decreased after deletion of Atad3a, which suggested that Atad3a was required for the B cell differentiation at a stage downstream of commitment to lymphoid progenitor cells. In support of that, Atad3a deficiency led to a reduction in B220
+ pro-B cells, pre-B cells and immature IgM + B cells, but the earlier B220 + pre-pro-B cell precursors were Mx1Cre mice (key). *P < 0.05, **P < 0.01 and ***P < 0.001 (Student's t-test). Data are from two independent experiments (averaged; mean ± s.d. of n = 8 mice per genotype (a,b,h), n = 6 mice per genotype (d,e) or n = 3 mice per genotype (g)).
increased ( Fig. 3h and Supplementary Fig. 3i ). Thus, Atad3a was required for efficient progression from pre-pro-B cell to pro-B cell.
Our data collectively demonstrated that Atad3a deficiency caused abnormal differentiation defects at multiple hematopoietic progenitor stages.
Atad3a suppresses Pink1-mediated mitophagy. To explore the possibility that the hematopoietic defects that occurred after deletion of Atad3a resulted from the deregulation of mitochondrial homeostasis, we assessed the properties of mitochondria in Atad3a-deficient bone-marrow cells. Atad3a deficiency caused a significant reduction in mitochondrial mass in various bonemarrow populations ( Fig. 4a and Supplementary Fig. 4a ). However, the average mitochondrial membrane potential of Atad3a-deficient bone-marrow cells, on the basis of mitochondrial content, was not reduced but was instead increased, as assessed by the ratio of cellular membrane potential to mitochondrial mass (Fig. 4b) . This might have partially compensated for the loss of mitochondrial mass. Consistent with the decreased mitochondrial mass, deletion of Atad3a diminished both the basal oxygen-consumption rate and the maximal oxidative capacity (Fig. 4c) . Although mitochondrial deregulation can alter the cellular ROS level and thus lead to defective maintenance of HSCs 32, 33 , we found no substantial change in ROS production after deletion of Atad3a (Supplementary Fig. 4b ). The ATP production of Atad3a-deficient cells was similar to that of Atad3a fl/fl cells ( Supplementary Fig. 4c ). Mitochondrial mass can be regulated by organelle biogenesis, which is affected by a series of transcription factors and co-activators, including PGCα , PGCβ , Errα , Nrf1 and Tfam 34, 35 . However, there was no substantial reduction in expression of the genes encoding these molecules after deletion of Atad3a ( Supplementary Fig. 4d , left). Atad3a-deficient cells and Atad3a fl/fl cells also had equivalent expression of the mitochondrial proteins Atp5g1, Cox5a, Cycs and Hsp60, which are encoded by the nuclear genes ( Supplementary  Fig. 4d, right) .
Mitochondrial mass can be regulated by mitophagy. Transmission-electron-microscopy analysis revealed that mitophagy occurred in Atad3a-deficient LSK cells but not in Atad3a fl/fl cells (Fig. 4d) , which indicated that the loss of Atad3a activated mitophagy to degrade mitochondria.
Mitophagy-dependent mitochondrial degradation can be prevented by the autophagy inhibitors chloroquine or bafilomycin A1. We quantified mitochondrial loss sensitive to chloroquine or bafilomycin A1 to quantify mitophagy relatively. Each drug prevented the loss of mitochondria induced by deletion of Atad3a ( Fig. 4e and Supplementary Fig. 4e ).
We further purified HSCs, MPPs and Lin -progenitor cells and quantified mitochondrial mass by measuring the ratio of mitochondrial DNA to nuclear DNA. This ratio was lower in purified Atad3a-deficient cells than in Atad3a fl/fl cells, and this reduction was significantly prevented by chloroquine (Fig. 4f) . Collectively, our data demonstrated that loss of Atad3a activated mitophagy to degrade mitochondria.
Mitophagy can be induced by stresses to remove damaged mitochondria with lower membrane potential than that of healthy mitochondria 15, 36 . Atad3a deficiency not only caused a reduction in the abundance of damaged mitochondria with low potential but also significantly decreased the abundance of healthy mitochondria with high potential (Fig. 5a-c) . These data suggested that Atad3a was needed to suppress the mitophagy of healthy mitochondria.
We sought to demonstrate mitophagy flux by measuring co-localization of the mitochondrial marker Tom20 with the lysosomal marker Lamp2a. Knockdown of Atad3a by short hairpin RNA (shRNA) significantly increased the co-colocalization of Tom20 with Lamp2a either in the absence of leupeptin, a lysosomal proteolysis inhibitor, or in its presence (Fig. 5d,e) . We also confirmed mitophagy flux by accumulation of the autophagy marker LC3-II in the intact mitochondrial fraction isolated from Atad3a-deficient Lin -progenitor cells in both the presence of chloroquine and its absence ( Fig. 6a and Supplementary Fig. 5a ). Consistent with that, autophagy flux (the ratio of LC3-II to LC3-I) was increased after deletion of Atad3a (Fig. 6a, bottom) .
The accumulation of Pink1 and subsequent recruitment of Parkin to the mitochondrial outer membrane have been shown to trigger mitophagy 20, 21, 37 . Loss of Atad3a led to increased abundance of Pink1 (Supplementary Fig. 5b ) and accumulation of Pink1 and Parkin in the mitochondrial fraction both with and without chloroquine treatment (Fig. 6a, top) . Parkin ubiquitinates multiple mitochondrial proteins. Consistent with that, we observed a profound increase in the polyubiquitination of global mitochondrial proteins after deletion of Atad3a (Fig. 6a, top) . These data suggested that Atad3a suppressed Pink1-mediated mitophagy. To further test that proposal, we generated HEK293T human embryonic kidney cells in which Atad3a was knocked down or both Atad3a and Pink1 were knocked down. Knockdown of Atad3a increased the abundance of Pink1, diminished mitochondrial mass and led to the accumulation of LC3-II, Pink1 and Parkin and of polyubiquinated proteins in the mitochondrial fraction (Fig. 6b,c) . Notably, all of those phenotypes were 'rescued' by simultaneous knockdown of Pink1 expression (Fig. 6b,c) . We did not detect any change in mitochondrial mass after knockdown of Pink1 alone (Supplementary Fig. 5c ).
The cleavage and degradation of Pink1 occurs after its import into the inner mitochondrial membrane 22, 38 . That processing depends on both the mitochondrial outer-membrane complex (TOM) and the mitochondrial inner-membrane complex (TIM) 23 . However, it is unclear which cellular factors mediate the transport of Pink1 from the outer membrane to the inner membrane. We found that the endogenous Atad3a interacted with both Tom40 and Tim23, the core components of the TOM complex and TIM complex, respectively (Fig. 6d) . Thus, Atad3a might serve as a bridging factor to facilitate the transport of Pink1. We further showed that Pink1 interacted with Atad3a in vivo and in vitro ( Supplementary Fig. 5d,e) . That interaction was lost in cells in which Tom40 was knocked down (Fig. 6e) . These findings suggested that in normal, healthy cells under physiological conditions, Pink1 might be presented to Atad3a through the TOM complex and then be transported to the TIM complex.
Loss of membrane potential caused by treatment with a combination of oligomycin and antimycin (OA) or with CCCP (a chemical inhibitor of oxidative phosphorylation) inhibits the import of Pink1 and leads to mitophagy 20, 38, 39 . However, the link between membrane potential and the import of Pink1 has remained elusive. Treatment with OA abolished the interaction between Atad3a and Tim23 but not the interaction of Atad3a with Tom40 (Fig. 6d) . That supported the hypothesis that loss of membrane potential induced mitophagy by disrupting an Atad3a-Tim23 complex and thereby blocked the transport of Pink1 (Supplementary Fig. 5f ). Consistent with that, treatment with OA severely inhibited the interaction of Pink1 with Tim23 (Fig. 6f) . Although treatment with OA or CCCP also decreased the co-immunoprecipitation of Atad3a or Tom40 with Pink1, as determined by their lower ratio to Pink1 than the ratio without treatment with OA or CCCP ( Fig. 6f and Supplementary  Fig. 5g ), the reduction in these ratios was due to the accumulation of Pink1.
To further investigate whether Atad3a was indeed required for the import of Pink1, we assessed the effects of its depletion on the detection of complexes of Pink1 with Tom40, Tim23 or the matrix Pink1 protease MPPβ . Knockdown of Atad3a largely decreased the interaction of Pink1 with Tim23 or MPPβ (Fig. 6g) . We also performed an in vitro assay of the import of Pink1 using isolated mitochondria. Mitochondria from cells in which Atad3a was knocked down showed impaired import of Pink1 relative to that of cells mitochondria isolated from control cells in which Atad3a was not knocked down, as determined by the accumulation of fulllength Pink1 protein and a relatively decreased abundance of its cleaved form (Fig. 6h) .
Atad3a is a mitochondrial AAA+ -ATPase whose N terminus interacts with the outer membrane 24 . We next investigated whether the ATPase activity or N terminus of Atad3a was required for the import of Pink1. For this, we generated the mutants Atad3a E412Q , which lacks ATPase activity, and Atad3a dN50 , which lacks the 50 amino acids of its N terminus 24 . Similar to wild-type Atad3a, Atad3a E412Q interacted with Tom40, Tim23 and Pink1 (Fig. 6i) . In cells in which Atad3a was knocked down, restoration of Atad3a with either wild-type Atad3a or Atad3a E412Q 'rescued' the abnormal accumulation of Pink1, the impaired interaction of Pink1 with Tim23 and the defective in vitro import of Pink1 (Fig. 6j,k) . In contrast, Atad3a dN50 neither interacted with Tom40 and Pink1 nor 'rescued'
the Atad3a-deficient phenotypes (Fig. 6i-k) . We noticed an additional band (an intermediate product) slightly below full-length Pink1 in the in vitro importation assay (Fig. 6k, lanes 1, 3, 5 ). Pink1 is sequentially processed by the proteases MPP and Parl
22
. The intermediate product was probably MPP-processed Pink1 that was not fully cleaved by Parl in the in vitro assay. Our data showed that the N terminus of Atad3a but not its ATPase activity was required for its importation.
Collectively, our data indicated a working model in which Atad3a serves as a bridging factor to facilitate the transport of Pink1 from the outer membrane of the mitochondria to its inner membrane for processing and thus maintains a low abundance of Pink1 and prevents mitophagy (Supplementary Fig. 5h ).
Atad3a regulates hematopoiesis by suppressing Pink1-dependent mitophagy. To determine whether activation of mitophagy is responsible for the aberrant hematopoietic differentiation in Atad3a-deficient bone marrow, we investigated whether the autophagymitophagy inhibitor chloroquine could reverse the phenotypic changes induced in the Atad3a fl/fl Mx1Cre mice. We confirmed by immunoblot analysis that treatment with this drug did not compromise the efficiency of Cre-mediated deletion of Atad3a (Fig. 7a) and observed that chloroquine did restore the number of total cells in bone marrow in which Atad3a was deleted (Fig. 7b) . Moreover, treatment of Atad3a-deficient mice with chloroquine significantly 'rescued' both the frequency and number of LT-HSCs, ST-HSCs, MPPs and LSK cells (Fig. 7c-e) . Chloroquine also reversed the reduction in CMPs and MEPs and eliminated the elevation in GMPs and CLPs (Fig. 7f-h and Supplementary Fig. 6a ).
We then investigated whether Pink1-dependent activation of mitophagy contributed to the defects seen in Atad3a-deficient bone marrow by crossing Atad3a fl/fl Mx1Cre with Pink1 −/− mice and establishing inducible double-deficient mice. Deletion of Pink1 in Atad3a-deficient mice prolonged their survival, completely restored the mitochondrial mass, abolished the recruitment of LC3-II to mitochondria and repressed the polyubiquitination of mitochondrial proteins (Fig. 8a-c) , which suggested that deletion of Pink1 suppressed the mitophagy activated by Atad3a deficiency. Accordingly, the mitochondrial membrane potential and oxygenconsumption defects in Atad3a-deficient cells were also significantly 'rescued' by deletion of Pink1 (Fig. 8d,e) . Consequently, loss of Pink1 restored the total bone-marrow cellularity that was reduced with Atad3a deficiency (Fig. 8f) . Moreover, deletion of both Pink1 and Atad3a significantly 'rescued' the proportion and absolute number of most of the stem and progenitor cell pools (with the exception of the number of CLPs), including the frequency of LT-HSCs, ST-HSCs, MPPs, LSK cells, GMPs, MEPs and CLPs and the number of LT-HSCs, ST-HSCs, MPPs, LSK cells, CMPs, GMPs and MEPs (Fig. 8g-j and Supplementary Fig. 6b-d) . Collectively, our data suggested that Atad3a-mediated suppression of Pink1-dependent mitophagy was critical for the maintaining the homeostasis of HSCs and progenitor cells.
We also assessed the effects of chloroquine and Pink1-Atad3a double knockout on the production of more-mature hematopoietic cells. We found that the reduced proportion of Ter119 + erythroid cells in Atad3a-deficient bone marrow was restored slightly by treatment with chloroquine and that the number of Ter119 + cells was partially 'rescued' by both chloroquine and double deficiency in Pink1 and Atad3a ( Supplementary Fig. 7a-e) . The reduced number of B220 + B cells was also partially restored by chloroquine and deletion of Pink1, but the increased number of Mac1 + cells was not ( Supplementary Fig. 7a-e) . Thus, Pink1-dependent suppression of mitophagy by Atad3a partially regulated populations of Lin + cells.
Discussion
The regulation of mitochondrial homeostasis during hematopoiesis has remained puzzling. Studies of mice with deletion of genes encoding essential molecules that promote autophagy (for example, Rb1cc1 (called 'Fip200' here), Atg7 or Atg12) have shown that inhibition of autophagy is associated with an accumulation of mitochondria and hematopoietic abnormalities [13] [14] [15] . Although all deletion of such genes (Fip200, Atg7 or Atg12) results in myeloid expansion, its effects on HSCs and myeloid progenitor cells are different. Deletion of Atg7 or Fip200 results in a decrease in HSCs and severe anemia, but Atg12-knockout mice are healthy with no anemia, and their number of HSCs does not change. In addition, Atg7 deficiency decreases GMPs while promoting mature myeloid proliferation, but deletion of Atg12 expands both GMP populations and mature myeloid populations. Such contrasting phenotypes of mice deficient in Atg12, Atg7 or Fip200 indicate that the inactivation of autophagy in hematopoiesis is more complicated than the deletion of a single gene encoding an autophagy-promoting molecule.
Mitophagy is a specific form of autophagy. The phenotypes of mice in which autophagy is inactivated might result not just from inhibition of mitophagy or accumulation of mitochondria. Indeed, Tie2
+ HSCs in which Parkin or Pink1 is knocked down 16 or LSK cells with low mitochondrial activity 40 show affected self-renewal ability but not myeloid-biased differentiation. Nevertheless, both of those two papers 16, 40 also have their limitations. In the first paper, Parkin or Pink1 was silenced to inhibit mitophagy in the isolated Tie2 + HSCs cultured in vitro, to prove the impaired population expansion of HSCs after inhibition of mitophagy 16 . It lacks genetic evidence to reflect the in vivo physiological conditions. Of note, both Pink1-knockout mice and Parkin-knockout mice are viable and display no defects in hematopoietic populations 15 . The second paper shows that 'TMRM low ' LSK cells (with low mitochondrial activity) display enhanced self-renewal ability 40 . However, the evidence in support of a role for mitophagy in the self-renewal ability HSCs in this paper 40 is not compelling, as it used only the chemical mitochondrial uncoupler FCCP, which might have other, off-target effects, to activate mitophagy 40 . Therefore, it is still unclear whether mitophagy regulates hematopoiesis in genetic mouse models.
Most notably, all of the currently published reports have sought to inhibit autophagy-mitophagy but not to hyperactivate or promote it. It remains unknown whether enhanced activation of mitophagy displays an opposite phenotype by clearing or diminishing the basal mitochondrial content, relative to the inhibition of mitophagy. Our study has provided critical answers to this important question. We have developed the first genetic mouse model, to our knowledge, with hyperactivation of mitophagy by deleting Atad3a in the hematopoietic system and have demonstrated that activation of mitophagy by inhibiting the import of Pink1 into mitochondria diminished the basal mitochondrial content, which led to blocked differentiation at certain stages and skewed stem-cell and progenitor pools. Our findings provide new insight into the critical role of mitophagy maintenance in hematopoiesis. An enhancement in mitophagy leads to abnormal hematopoietic phenotypes.
Published studies using a mitophagy-defective model have demonstrated that suppression of mitophagy blocks the maturation of terminal erythrocytes but increases the abundance of immature erythroid cells 41, 42 , which suggests that basal mitophagy is required for terminal erythrocyte maturation but not for erythroid progenitor differentiation. However, whether enhanced activation of mitophagy affects erythroid progenitor differentiation and erythroid maturation or not is unclear. Our data derived from the hyperactivated-mitophagy mouse model showed that both progenitor erythroid cells and mature erythroid cells were diminished after mitophagy was induced, which suggests that hyperactivation of mitophagy impairs the differentiation of erythroid lineages at the progenitor stage and leads to the depletion of erythroid-lineage cells. Our data, along with the results of previous studies, collectively demonstrate that defects in basal mitophagy and hyperactivation of mitophagy both lead to blocked erythoid differentiation at different stages.
The kinase Pink1 is a key driver of mitophagy. The majority of Pink1 is rapidly degraded after its import into mitochondria and is processed by the mitochondrial peptidases MPP and Parl 22 . Loss of mitochondrial membrane potential prevents the import of Pink1, which causes its accumulation at the mitochondrial surface. This leads to the recruitment of Parkin, the recruitment of mitochondrial proteins and the activation of mitophagy 20, 21 . However, how loss of membrane potential blocks the import of Pink1 has remained unclear. Our data have shown that accumulation of Pink1 after loss of membrane potential required dissociation of the TIM complex from Atad3a.
Our findings suggest that Atad3a serves as a key factor for the import of Pink1 and its processing to suppress unnecessary mitophagy and therefore maintains the normal differentiation of stem cells and progenitor cells. Thus, Pink1-dependent mitophagy should be suppressed to critically maintain mitochondrial homeostasis and normal pools of stem cells and progenitor cells. Our findings suggest that Pink1-dependent hyperactivation of mitophagy might be associated with some hematopoietic disorders and that targeting excessive mitophagy or Pink1 offers a potential therapeutic strategy for such diseases.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-017-0002-1.
transfected into HEK293T cells and Pink1 protein was purified. The same amount of Flag-tagged Pink1 was mixed with mitochondria isolated from HEK293T cells in which Atad3a was knocked down or not or from HEK293T cells in which Atad3a was knocked down and that were engineered to overexpress wild-type or mutant Atad3a, in importation assay buffer containing 20 mM HEPES (pH 7.4), 250 mM Sucrose, 80 mM KAc, 5 mM Mg(Ac)2, 2 mM ATP and 2 mM NADH, followed by incubation at 30 °C for 1 h. The mitochondria were then washed twice and analyzed by immunoblot.
In vitro binding assay. Purified Flag-tagged Pink1 and Myc-tagged Atad3a were incubated in buffer containing 20 mM HEPES (pH7.4), 150 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, 0.5 mM EDTA, 0.05% NP40 abd 10% glycerol with a proteinase inhibitor cocktail and were rotated at 4 °C overnight, then immunoprecipitated by anti-Myc and analyzed for Pink1 and Atad3a.
Statistical analysis. Kaplan-Meier mouse-survival data were statistically analyzed by the log-rank (Mantel Cox) test. To compare two groups, data were analyzed by a two-sided Student's t-test. For more than two groups, the data were analyzed by one-way ANOVA followed by Bonferroni post-hoc test. Data are presented as mean ± s.d. (SD). P < 0.05 was considered statistically significant. * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001. 
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